Chronic Kidney Disease – Anemia of Chronic Kidney Disease Will New Agents Deliver on Their Promise?
Chronic Kidney Disease: Eight weeks of treatment with the guanylate cyclase inhibitor (Bayer) reduced albuminuria by 40% compared with baseline and placebo in patients with type 2 diabetes. This is a simple course Creatinine (UACR). The third part, which was presented in two studies presented at the European Renal Association conference, showed the effectiveness and […]